BackPiramal Pharma Limited Overview

Piramal Pharma Limited Total Current Liabilities

Latest total current liabilities for PPLPHARMA.BO: $52B.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$51.59B
↑ 24.01% YoYΔ $9.99B vs prior year quarter

Peer trimmed avg / median

Loading

Piramal Pharma Limited Total Current Liabilities History

Loading

Piramal Pharma Limited vs. peers: Total Current Liabilities Comparison

Loading

Piramal Pharma Limited Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Piramal Pharma Limited (PPLPHARMA.BO) FAQ

As of the most recent data (September 2026), PPLPHARMA.BO shows a total current liabilities of $52B. That compares with $42B in the prior-year period — up 24.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PPLPHARMA.BO's total current liabilities is now $52B (was $42B) — a 24.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Piramal Pharma Limited is outperforming or lagging.

Tracking PPLPHARMA.BO's total current liabilities over time shows whether Piramal Pharma Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $52B That compares with $42B in the prior-year period — up 24.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Piramal Pharma Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $52B) with ownership activity and broader fundamentals.